Neural stem cells have been used as substrate for transformation to high-grade glioma when tumour suppressors, p16INK4a and p19ARF, were knocked out and active forms of epidermal growth factor receptor (EGFR) were introduced [29]. Here, CDKN2A is linked to glioma.